Status:
COMPLETED
A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Generalized Anxiety Disorder
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The study will look at the effectiveness of MK0777 in patients with Generalized Anxiety Disorder.
Eligibility Criteria
Inclusion
- Male or Female
- Current diagnosis of Generalized Anxiety Disorder
- Age 18 - 70
Exclusion
- Women who are pregnant, or breast-feeding
- Use of illicit drugs
- History of drug or alcohol dependence
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2003
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT00703833
Start Date
September 1 2002
End Date
February 1 2003
Last Update
November 2 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.